Exponent, Inc. (NASDAQ:EXPO)‘s stock had its “buy” rating reiterated by stock analysts at Cantor Fitzgerald in a report released on Wednesday. They presently have a $75.00 price objective on the business services provider’s stock, up from their previous price objective of $69.00. Cantor Fitzgerald’s target price suggests a potential upside of 14.94% from the stock’s current price.

The analysts wrote, “Foresi’s Take. Exponent posted strong revenue growth in the mid-double digits as recent headwinds have begun to subside and the company saw strength in multiple business lines. Lingering headwinds in a couple of areas were more than offset by strong quarters in biomedical, construction consulting, electrical engineering and polymer science practices, and work at a large human factors assessment project for a client in the consumer products industry. The automotive business still faced some challenges, but returned to growth, driven by work on new transportation technologies.””

A number of other research firms have also issued reports on EXPO. BidaskClub lowered Exponent from a “sell” rating to a “strong sell” rating in a report on Tuesday, June 27th. Zacks Investment Research lowered Exponent from a “buy” rating to a “hold” rating in a report on Wednesday, April 19th.

Shares of Exponent (EXPO) traded down 1.14% during trading on Wednesday, reaching $65.25. The company had a trading volume of 129,671 shares. Exponent has a 12 month low of $48.42 and a 12 month high of $68.30. The stock’s 50-day moving average price is $59.23 and its 200-day moving average price is $59.06. The stock has a market capitalization of $1.72 billion, a PE ratio of 33.83 and a beta of 0.60.

Exponent (NASDAQ:EXPO) last released its earnings results on Tuesday, July 18th. The business services provider reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.10. The firm had revenue of $84.10 million during the quarter, compared to the consensus estimate of $79.30 million. Exponent had a return on equity of 16.52% and a net margin of 15.94%. The firm’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.38 earnings per share. Equities analysts forecast that Exponent will post $1.90 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/07/23/exponents-nasdaqexpo-buy-rating-reiterated-at-cantor-fitzgerald.html.

Institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC bought a new position in Exponent during the first quarter worth $123,000. Ameritas Investment Partners Inc. acquired a new position in Exponent during the first quarter valued at approximately $132,000. Victory Capital Management Inc. increased its position in Exponent by 9.2% in the first quarter. Victory Capital Management Inc. now owns 2,683 shares of the business services provider’s stock valued at $160,000 after buying an additional 226 shares during the last quarter. State of Alaska Department of Revenue increased its position in Exponent by 0.7% in the first quarter. State of Alaska Department of Revenue now owns 2,830 shares of the business services provider’s stock valued at $168,000 after buying an additional 20 shares during the last quarter. Finally, Bank of Montreal Can increased its position in Exponent by 0.7% in the second quarter. Bank of Montreal Can now owns 3,231 shares of the business services provider’s stock valued at $189,000 after buying an additional 22 shares during the last quarter. 90.22% of the stock is currently owned by institutional investors and hedge funds.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.